NASDAQ · Biotechnology

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock

$3.13 +5.32% NASDAQ: CUPR Healthcare

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds.

Valuation

MetricValue
Price$3.13
Market Cap$8.39M
P/E Ratio-2.18
P/B Ratio2.03
P/S Ratio215.40
EPS (TTM)$-1.84
52-Week High$76.00
52-Week Low$1.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-100.00%
ROA-54.95%
ROCE-84.76%
Gross Margin-1.29%
Operating Margin-91.55%
Net Margin0.00%
Debt/Equity0.10
Current Ratio2.35

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-2.0M$-5.0M
Net Profit$-1.0M$-1.0M$-1.0M$-2.0M$-5.0M
EPS$-0.20$-0.43$-0.41$-0.57$-1.84
Op Margin-944.8%-2077.4%-1060.1%-3404.8%-9154.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$2.0M$2.0M$9.0M
Total Liabilities$2.0M$3.0M$4.0M$6.0M$3.0M
Cash$1.0M$1.0M$0$0$3.0M
Borrowings$0$0$0$0$0

Latest News

Top Premarket Gainers MT Newswires · Jun 24, 2026 Top Premarket Decliners MT Newswires · Jun 16, 2026 Sector Update: Healthcare Stocks Softer Late Afternoon MT Newswires · Jun 15, 2026 Top Midday Gainers MT Newswires · Jun 15, 2026 Sector Update: Healthcare Stocks Softer Monday Afternoon MT Newswires · Jun 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-2.0M$-2.0M$-1.0M$-9.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$2.0M$1.0M$1.0M$-5.0M
Net Cash Flow$1.0M$0$-1.0M$0$3.0M
Free Cash Flow$0$-2.0M$-2.0M$-1.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-1.71
FCF Yield-88.11%
Quick Ratio2.35
Interest Coverage-310.21
Return 1Y-95.37%
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held1.22%
Institutions Float Held1.22%
Institutional HolderSharesReport Date
Citadel Advisors Llc4,6602026-03-31
Xtx Topco Ltd4,4322026-03-31
Prospect Financial Group LLC 1,9152026-03-31
UBS Group AG452026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASBP $7.26 +3.13% -0.74 $837601 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%
CURX $0.18 -2.61% -1.94 $5.19M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is led by CEO Yong Qi Quek, employs 15 people, headquartered in SG, publicly traded since 2025.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock trades at $3.13 with a market capitalization of $8.39M. The stock is valued at a price-to-earnings (P/E) ratio of -2.18, price-to-book of 2.03, price-to-sales of 215.40. Over the past 52 weeks the stock has ranged between $1.76 and $76.00, and currently trades 95.9% below its 52-week high.

On profitability, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares generates a return on equity (ROE) of -100.00%, return on capital employed of -84.76%, an operating margin of -91.55%, a net profit margin of 0.00%.

Official website: www.cuprina.com.sg

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides